The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(2-((1H-pyrrol-2-yl)methylene)-3-methoxy-2H-pyrrol-5-yl)-5-bromo-1H-indole ID: ALA2172435
PubChem CID: 71460757
Max Phase: Preclinical
Molecular Formula: C18H14BrN3O
Molecular Weight: 368.23
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COC1=CC(c2cc3cc(Br)ccc3[nH]2)=N/C1=C\c1ccc[nH]1
Standard InChI: InChI=1S/C18H14BrN3O/c1-23-18-10-16(22-17(18)9-13-3-2-6-20-13)15-8-11-7-12(19)4-5-14(11)21-15/h2-10,20-21H,1H3/b17-9-
Standard InChI Key: WPWHOLNDAGSQAT-MFOYZWKCSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
12.3620 -17.3439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5749 -18.1409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3986 -18.1848 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.6951 -17.4148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0544 -16.8952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4934 -17.2017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0771 -17.7864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0982 -16.0700 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.8348 -15.6956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9439 -18.5977 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.6798 -18.9734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2646 -18.3896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8900 -17.6532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0566 -18.7864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2314 -18.7425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2696 -19.5847 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.5764 -20.0343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9383 -19.5120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1691 -19.8038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0369 -20.6174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6799 -21.1385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4466 -20.8440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2648 -20.9118 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 1 2 0
4 6 2 0
6 7 1 0
5 8 1 0
8 9 1 0
7 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 7 2 0
14 15 2 0
15 18 1 0
17 16 1 0
16 14 1 0
2 14 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
20 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 368.23Molecular Weight (Monoisotopic): 367.0320AlogP: 4.63#Rotatable Bonds: 3Polar Surface Area: 53.17Molecular Species: NEUTRALHBA: 2HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.88CX Basic pKa: 3.92CX LogP: 3.20CX LogD: 3.20Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.70Np Likeness Score: -0.45
References 1. Su JC, Chen KF, Chen WL, Liu CY, Huang JW, Tai WT, Chen PJ, Kim I, Shiau CW.. (2012) Synthesis and biological activity of obatoclax derivatives as novel and potent SHP-1 agonists., 56 [PMID:22982119 ] [10.1016/j.ejmech.2012.08.024 ]